Skip to content

Category: Press releases

Docrates Cancer Center has appointed Anna-Sofia Malmi as Marketing and Communications Director

By Jonna

”I’m truly pleased to welcome Anna-Sofia to lead our company’s marketing and communications team. Anna-Sofia has extensive experience about developing energy company’s comprehensive brand in the Nordics outside our industry sector. Her energetic grip and strong track record in marketing and communications functions will support us when creating Finnish our successful story in cancer treatment … Continued

“The future of cancer treatment” is already a reality in Finland – gene profiling may benefit all cancer patients

By Lotta Mitro

– Gene profiling benefits approximately 20% of cancer patients by providing support for decision-making regarding medication and treatment, and it can be helpful for all cancer patients. In some cancers, gene profiling directly guides the selection of drug therapy; some drugs, for example, are only effective if the tumor has a specific mutation. However, the … Continued

A surprising silver lining of the pandemic? – Chief Clinical Director: RNA vaccines can be very helpful in cancer treatment

By Lotta Mitro

RNA vaccines are not yet used in cancer treatment, but this may change soon, according to Docrates Cancer Center’s Chief Clinical Director Juha Kononen. “RNA vaccines have provided good protection against COVID-19 infections, which indicates that they create a good immune response. Positive experiences have backed up the idea in cancer treatment that the same … Continued

Finnish AI software improves cancer patient care

By jere@donbranco.fi

Radiotherapy plays an important role in cancer treatment. For each cancer patient receiving radiation treatment, a detailed treatment plan is compiled to determine where and how radiotherapy is delivered. Factors to consider in a treatment plan include the size and location of the tumor, as well as possible metastases. Thus far, a physician has had … Continued

Long-term follow-up results of interstitial HDR brachytherapy in prostate cancer treatment seem very promising

By jere@donbranco.fi

Over 1,000 HDR procedures have been performed at the Docrates Cancer Center, and based on the long-term follow-up, using HDR therapy as the only treatment method is a safe and efficient method for patients who suffer from a low-risk localised prostate cancer. Using HDR brachytherapy as a treatment method in addition to conventional external radiotherapy … Continued